Several high profile cases in the last year have demonstrated how the cost for life-saving drugs or treatment can increase dramatically without warning. The narratives of Epipen and the anti-parasitic drug Daraprim tell the heart-rending tale of patients abruptly unable to afford a drug that they desperately needed.